Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NSAID APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Imrecoxib via dihydrofuranone intermediate. Eliminates chromium toxicity, reduces cost, and ensures supply continuity for API manufacturing.
Patent CN103145574A reveals a cost-effective Diclofenac route using N-chloroamide cyclization. Ideal for reliable pharmaceutical intermediates supplier seeking scalable API manufacturing.
Patent CN112225657B reveals a green aqueous Suzuki coupling for Flurbiprofen. Discover cost-effective manufacturing and high-purity supply chain solutions.